Search Results

Ferring Pharmaceuticals and BioInnovation announce a new strategic collaboration to accelerate innovation in women’s health.

Chiesi Global Rare Diseases announced a U.S. Networkwide Sponsorship of BioInnovation Labs, the leading developer and operator of life science coworking spaces with 12 active facilities and a growing network in the U.S. and internationally.

Orion Corporation and Glykos Finland Oy announced that they have entered into a research collaboration and licensing agreement to develop next-generation antibody-drug conjugates.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company, with a term beginning effective September 1, 2020. Douglass Given, M.D., Ph.D., Chairman of the Board of Arrowhead, said, “Oye is a senior physician executive, with deep scientific and clinical development ex

Immugenia Inc. has announced that adMare BioInnovations, ACET Capital 2, and Sherbrooke Innopole have joined forces to support the development of immunity therapy programs based on the work of Dr. Elie Haddad, clinical researcher at CHU Sainte-Justine and professor at the Université de Montréal’s pediatrics department.